Search all medical codes

Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

HCPCS code

Medical Policies and Guidelines for Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Related policies from health plans

Yescarta (axicabtagene ciloleucel)

Similar Codes


ICD10CM codes

Z92.850 - Personal history of Chimeric Antigen Receptor T-cell therapy
Z52.011 - Autologous donor, stem cells
Z92.85 - Personal history of cellular therapy
Z92.858 - Personal history of other cellular therapy
Z92.859 - Personal history of cellular therapy, unspecified
C92.1 - Chronic myeloid leukemia, BCR/ABL-positive
C92.11 - Chronic myeloid leukemia, BCR/ABL-positive, in remission
Z52.010 - Autologous donor, whole blood
C92.21 - Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
T80.82XA - Complication of immune effector cellular therapy, initial encounter

HCPCS codes

Q2041 - Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, includi
Q2043 - Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leuk
A9543 - Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries
A9569 - Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose
A9570 - Indium in-111 labeled autologous white blood cells, diagnostic, per study dose
S2142 - Cord blood-derived stem-cell transplantation, allogeneic
A9560 - Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries
P9052 - Platelets, hla-matched leukocytes reduced, apheresis/pheresis, each unit
A9568 - Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries
P9053 - Platelets, pheresis, leukocytes reduced, cmv-negative, irradiated, each unit

CPT4 codes

0537T - Chimeric antigen receptor T-cell (CAR-T) therapy; harvesting of blood-derived T lymphocytes for deve
0538T - Chimeric antigen receptor T-cell (CAR-T) therapy; preparation of blood-derived T lymphocytes for tra
38206 - Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologo
38241 - Hematopoietic progenitor cell (HPC); autologous transplantation
38205 - Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; allogene
38242 - Allogeneic lymphocyte infusions
36513 - Therapeutic apheresis; for platelets
0263T - Intramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple inj
36511 - Therapeutic apheresis; for white blood cells
86950 - Leukocyte transfusion